Physician profile
Lei Chu
NPI 1831354851
$9,636.74
in general payments reported to CMS, 2019-2025
34 companies · $328 in 2025
The $328 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,670 · 2020: $156 · 2021: $595 · 2022: $811 · 2023: $579 · 2024: $5,496 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,785 · Food and Beverage: $1,618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,785.03 |
| Food and Beverage | $1,618.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,500.00 | 2024 | |
| Neotract INC. | $851.57 | 2019 | |
| Antares Pharma, INC. | $633.59 | 2020-2025 | Xyosted, Nocdurna, Tlando |
| Astellas Pharma US INC | $534.58 | 2021-2024 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $471.01 | 2023-2025 | Gemtesa, Myfembree |
| Olympus America INC. | $399.81 | 2019-2023 | Itind System |
| Urovant Sciences INC | $380.52 | 2021-2022 | |
| Axonics, INC. | $306.71 | 2021-2024 | Axonics |
| Medtronic USA, INC. | $304.09 | 2019-2020 | |
| Boston Scientific Corporation | $239.33 | 2021-2025 | Axonics, Rezum Generator |
| Medtronic, INC. | $201.32 | 2021-2024 | Interstim |
| Pfizer INC. | $146.37 | 2019-2021 | |
| Halozyme INC | $59.44 | 2023 | |
| Urogen Pharma, INC. | $58.80 | 2024 | |
| Azurity Pharmaceuticals, INC. | $42.69 | 2025 | Azmiro |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $42.25 | 2022-2025 | Trelstar |
| Endo Pharmaceuticals INC. | $41.44 | 2019-2022 | |
| Caldera Medical, INC | $41.39 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $36.91 | 2020 | |
| Laborie Medical Technologies Corp. | $34.69 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Acerus Pharmaceuticals Corporation | $31.67 | 2021-2022 | |
| Coloplast Corp | $29.52 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $29.28 | 2019 | |
| Procept Biorobotics Corporation | $28.15 | 2022 | |
| Amniox Medical, INC. | $27.36 | 2020 | |
| Telix Pharmaceuticals | $26.48 | 2023 | Illuccix |
| Mission Pharmacal Company | $26.21 | 2019 | |
| Janssen Biotech, INC. | $20.79 | 2022 | |
| Therapeuticsmd, INC. | $20.10 | 2019 | |
| Myriad Genetic Laboratories, INC. | $18.50 | 2021 | |
| Biotissue Holdings INC. | $14.73 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.33 | 2023 | Seglentis |
| Convatec INC. | $11.67 | 2021 | |
| Abbott Laboratories | $11.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lei Chu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.